The Valley Desk

NCT04426695 · Interventional trial

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19

Overall registry status Completed

Phase 1 · Phase 2

Conditions COVID-19

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov